- Home
- BODI vs CLNN Comparison
BODI vs CLNN Comparison
Compare BODI & CLNN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BODI
- CLNN
- Stock Information
- Founded
- BODI 1998
- CLNN 2012
- Country
- BODI United States
- CLNN United States
- Employees
- BODI N/A
- CLNN N/A
- Industry
- BODI Industrial Machinery/Components
- CLNN Biotechnology: Pharmaceutical Preparations
- Sector
- BODI Industrials
- CLNN Health Care
- Exchange
- BODI Nasdaq
- CLNN Nasdaq
- Market Cap
- BODI 47.1M
- CLNN 43.0M
- IPO Year
- BODI N/A
- CLNN N/A
- Fundamental
- Price
- BODI $6.31
- CLNN $4.34
- Analyst Decision
- BODI Strong Buy
- CLNN Strong Buy
- Analyst Count
- BODI 3
- CLNN 4
- Target Price
- BODI $12.33
- CLNN $55.25
- AVG Volume (30 Days)
- BODI 9.8K
- CLNN 121.1K
- Earning Date
- BODI 11-12-2024
- CLNN 11-13-2024
- Dividend Yield
- BODI N/A
- CLNN N/A
- EPS Growth
- BODI N/A
- CLNN N/A
- EPS
- BODI N/A
- CLNN N/A
- Revenue
- BODI $451,432,000.00
- CLNN $421,000.00
- Revenue This Year
- BODI N/A
- CLNN N/A
- Revenue Next Year
- BODI N/A
- CLNN N/A
- P/E Ratio
- BODI N/A
- CLNN N/A
- Revenue Growth
- BODI N/A
- CLNN N/A
- 52 Week Low
- BODI $5.14
- CLNN $3.82
- 52 Week High
- BODI $13.45
- CLNN $12.00
- Technical
- Relative Strength Index (RSI)
- BODI 47.28
- CLNN 44.40
- Support Level
- BODI $6.08
- CLNN $4.22
- Resistance Level
- BODI $7.00
- CLNN $5.47
- Average True Range (ATR)
- BODI 0.25
- CLNN 0.45
- MACD
- BODI 0.04
- CLNN 0.06
- Stochastic Oscillator
- BODI 25.00
- CLNN 30.57
About BODI The Beachbody Company Inc. Class A Common Stock
The Beachbody Co Inc is a health and wellness platform providing fitness, nutrition and stress-reducing programs to its customers. The product offerings of the company include Digital Subscriptions, Nutritional Products, and Connected Fitness Products. It earns the majority of its revenue from the United States. The company operates and manages its business in two operating segments, Beachbody and Other.
About CLNN Clene Inc.
Clene Inc is a clinical-stage pharmaceutical company pioneering the discovery, development, and commercialization of novel clean-surfaced nanotechnology (CSN) therapeutics. It is focused on the development of therapeutics for neurodegenerative diseases. It developed an electro-crystal-chemistry drug development platform that enables the production of concentrated, stable, clean-surfaced nanocrystal suspensions. It operates in one segment the development and commercialization of dietary supplements (Supplements).